1. Effect of Empagliflozin on Multiple Biomarkers in Heart Failure: Insights From the Empire Heart Failure Trial. (21st April 2022) Authors: Jensen, Jesper; Omar, Massar; Kistorp, Caroline; Tuxen, Christian; Poulsen, Mikael Kjær; Faber, Jens; Køber, Lars; Gustafsson, Finn; Møller, Jacob Eifer; Schou, Morten Journal: Circulation Issue: Volume 15:Number 8(2022) Page Start: e009333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of extended follow‐up in a specialized heart failure clinic on adherence to guideline recommended therapy: NorthStar Adherence Study. (14th October 2014) Authors: Schou, Morten; Gislason, Gunnar; Videbaek, Lars; Kober, Lars; Tuxen, Christian; Torp‐Pedersen, Christian; Hildebrandt, Per R.; Gustafsson, Finn; on behalf of the NorthStar Investigators Journal: European journal of heart failure Issue: Volume 16:Number 11(2014) Page Start: 1249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trial. (14th December 2022) Authors: Fuchs Andersen, Camilla; Omar, Massar; Glenthøj, Andreas; El Fassi, Daniel; Møller, Holger J.; Lindholm Kurtzhals, Jørgen A.; Styrishave, Bjarne; Kistorp, Caroline; Tuxen, Christian; Poulsen, Mikael K.; Faber, Jens; Køber, Lars; Gustafsson, Finn; Møller, Jacob E.; Schou, Morten; Jensen, Jesper Journal: European journal of heart failure Issue: Volume 25:Number 2(2023) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial. Issue 2 (February 2021) Authors: Jensen, Jesper; Omar, Massar; Kistorp, Caroline; Tuxen, Christian; Gustafsson, Ida; Køber, Lars; Gustafsson, Finn; Faber, Jens; Malik, Mariam Elmegaard; Fosbøl, Emil Loldrup; Bruun, Niels Eske; Forman, Julie Lyng; Jensen, Lars Thorbjørn; Møller, Jacob Eifer; Schou, Morten Journal: Lancet Issue: Volume 9:Issue 2(2021) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve. Issue 1 (December 2017) Authors: Holmager, Pernille; Egstrup, Michael; Gustafsson, Ida; Schou, Morten; Dahl, Jordi; Rasmussen, Lars; Møller, Jacob; Tuxen, Christian; Faber, Jens; Kistorp, Caroline Journal: BMC cardiovascular disorders Issue: Volume 17:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Metabolic Effects of Empagliflozin in Heart Failure: A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic). Issue 22 (2nd June 2021) Authors: Jensen, Jesper; Omar, Massar; Kistorp, Caroline; Tuxen, Christian; Gustafsson, Ida; Køber, Lars; Gustafsson, Finn; Faber, Jens; Forman, Julie L.; Møller, Jacob E.; Schou, Morten Journal: Circulation Issue: Volume 143:Issue 22(2021) Page Start: 2208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗